Detalhe da pesquisa
1.
Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis.
BMC Gastroenterol
; 23(1): 212, 2023 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37337148
2.
How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches.
J Clin Med
; 10(7)2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33915839
3.
Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer.
Cancers (Basel)
; 13(7)2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33916221
4.
Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?
Cancers (Basel)
; 13(17)2021 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503206
5.
The Emergence of Immune-checkpoint Inhibitors in Colorectal Cancer Therapy.
Curr Drug Targets
; 22(9): 1021-1033, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563194
6.
MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer.
Clin Cancer Res
; 26(1): 183-192, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31852830
7.
Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?
Cancers (Basel)
; 11(8)2019 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31374916
8.
Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer Center.
Cancers (Basel)
; 11(10)2019 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31615124
9.
Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies.
Cancers (Basel)
; 11(8)2019 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31416208
10.
ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK.
Clin Colorectal Cancer
; 18(4): 280-291.e5, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31451367
11.
Circulating tumour DNA, a promising biomarker for the management of colorectal cancer.
Crit Rev Oncol Hematol
; 122: 72-82, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29458792
12.
Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy.
ESMO Open
; 2(1): e000101, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28761723
13.
A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.
Trials
; 18(1): 394, 2017 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28851403